^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Breast Cancer |
| Drug: | zoledronic acid (Bone resorption factor inhibitor, Osteoclast inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
01/18/2022
Excerpt:
When an adjuvant bisphosphonate is used to prevent breast cancer recurrence, the therapeutic options recommended by the Panel include oral clodronate, oral ibandronate, and intravenous zoledronic acid.
DOI:
10.1200/JCO.21.02647
